Ernexa Therapeutics, Inc. (ERNA)

1.97 -0.14 (-6.64%) USD  |  NASDAQ  |  Oct 30, 16:00
1.95 -0.02 (-1.02%) After-Hours: 20:00
More

Ernexa Therapeutics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for ERNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2026. Start Trial.
Date Value
July 29, 2026 --
June 30, 2026 --
May 27, 2026 --
Date Value
May 08, 2026 --
March 31, 2026 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Cerenome, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade